IL13 and Parkinson disease: Interestingly, SKF, a compound that attenuates inflammation by inhibiting p38α/β, could lead to a decrease in the levels of TNF, IL-6, and IL-13 in the murine model of PD, suggesting that the MAPK pathway may occupy a vital role in regulating PD [202].